Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Waters and SOTAX Group Sign Co-Marketing and Re-Seller Agreement

Waters Corporation
Posted on: 01 Nov 16

Waters Corporation (NYSE:WAT) announced today that it has entered into an agreement with the SOTAX Group, a global developer and manufacturer of equipment for dissolution testing, automated sample preparation, and physical testing of pharmaceutical dosage forms. Under the terms of the agreement, Waters will make available to SOTAX its ACQUITY UPLC® H-Class System for sale to drug manufacturers performing small-molecule, solid-dosage analysis in quality control and analytical research and development.

“Improved sample preparation to keep pace with the speed of our ACQUITY UPLC instrumentation platform has often been requested by our customers,” said Mike Harrington, Ph.D., Senior Vice President – Global Markets. “This exciting new collaboration links Waters and SOTAX technologies enabling our mutual customers to streamline their analysis, characterization and preparation of pharmaceutical samples, and improve their productivity and profitability.”

Under the terms of the agreement, Waters licenses SOTAX as an independent distributor for the Waters ACQUITY UPLC H-Class System. SOTAX will market, sell and distribute the ACQUITY UPLC H-Class System through its own direct sales force to pharmaceutical laboratories in the following countries: United States, Canada, United Kingdom, France, Germany, Italy, Switzerland and the Czech Republic.

“Working closely with Waters will allow us to generate significant value for our mutual customers in the current, data integrity driven environment. We are excited to have been selected by Waters to collaborate in the dissolution testing and sample preparation space,” said Patrick Ballmer, Vice President at SOTAX Group.

About SOTAX
SOTAX is the international leader in the development and manufacturing of fully automated systems for dissolution testing, sample preparation, and physical testing of pharmaceutical dosage forms. With over 40 years of sustained growth, SOTAX is now the world’s largest company focused on the dissolution testing space.

About Waters Corporation ( www.waters.com )
Waters Corporation (NYSE:WAT) develops and manufactures advanced analytical and material science technologies for laboratory dependent organizations. For more than 50 years, the company has pioneered a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis systems.

Waters, UPLC, ACQUITY, ACQUITY UPLC and are trademarks of Waters Corporation. SOTAX is a trademark of SOTAX AG.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161101006567/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.